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Abstract
Background: Hepatitis B virus (HBV) infection remains a major global health problem. This study aimed to assess
the prevalence and risk behaviors for HBV infection among high risk groups in Kohgiloyeh and Boyerahmad
province, in Southwest of Iran.
Methods: Blood samples were collected from 2009 subjects, between 2009 and 2010 in Kohgiloyeh and
Boyerahmad province, in southwest of Iran. Recruited subjects were the high risk groups for HBV infection,
including inmates, injecting drug users, health care workers, patients on maintenance haemodialysis, hemophilic
patients and patients with a history of blood transfusion. Their serum samples were tested for the presence of
antibodies to hepatitis B core antigen (HBc IgM, IgG) by enzyme-linked immunosorbent assay (ELISA). Seropositive
specimens were tested for HBsAg. Demographic features of participants were recorded during sample collecting.
Results: HBsAg was detected in 24 of the 2009 subjects, giving an overall prevalence of 1.2%. All HBsAg positive
cases were males. The prevalence of HBsAg among injection drug users was 3.2%. Significant correlation was found
between HBV infection and drug abuse, level of education and place of residence (p<0.05), while no significant
correlation was found between HBV infection and previous history of blood transfusion, unprotected sexual
behavior, and thalassemia.
Conclusion: Based on the findings of this study, incarceration and drug abuse are the most important risk factors
for acquiring HBV infection in this region. Modifying behavior, improving the individual education and expanding
the HBV vaccination coverage may reduce the rate of infection in the region.
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Background
Hepatitis B virus (HBV) a member of hepadenaviridae
family is the causative agent of hepatitis B infection. This
infection remains a major global public health problem. In
spite of the availability of a highly effective vaccine against
hepatitis B infection, the overall burden of the disease
remains enormous with over two billion people infected
worldwide and about one million deaths annually [1,2].
It has been estimated that at the most, 33% of the
infected people have evidence of clinical hepatitis, and
depending on the age of infection, up to one third of
infected patients become chronic carriers of hepatitis B
surface antigen (HBsAg) [3].
Transmissions may occur through sexual intercourse,
parenteral contact or from an infected mother to the
baby at birth (4). HBV also shares similar characteristics
to the HIV transmission, the virus has been detected in
peripheral mononuclear cells, tissue of pancreas, kidney,
skin, and spleen and of fluids like semen, breast milk,
sweat, tears, urine and vaginal secretion [4,5].
The prevalence of hepatitis B infection varies in different
parts of the world, ranging from less than 1% to 15%. In
the Middle East, the endemicity is intermittent, with a car-
rier rate of 2% to 8% [6-9].
A systematic review on HBV infection in Iran revealed
that prevalence of this infection is approximately 2.14%
(range, 1.3% to 6.3%) across provinces [10]. The prevalence
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of HBV infection is higher among males than females in
Iran [10]. Knowledge about the rate of hepatitis B infec-
tion and its related risk factors are necessary for imple-
mentating any preventive program. The present study was
conducted to assess the prevalence and risk behaviors
associated with HBV infection among high risk groups in
Kohgiloyeh and Boyerahmad province, in Southwest of
Iran. These high risk groups are the most vulnerable
groups for acquiring HBV infection and have not been
looked at in prior prevalence studies in the region.
Methods
This descriptive cross-sectional study was carried out in
Kohgiloyeh and Boyerahmad province, in southwest of Iran.
A structured questionnaire containing demographics data
such as age, gender, education level was used to collect the
data. High risk populations for HBV infection including
those who had a history of blood transfusion, history of
intravenous drug use, history of incarceration, those with
unsafe sexual activities, health care workers, patients on
maintenance haemodialysis, hemophilic patients from main
three townships of the province (Yasouj, Gachsaran, and
Dehdasht) were the subjects of this study.
After getting approval from the ethics committee of
Yasouj University of Medical Sciences, 5 ml of blood sam-
ples were obtained from each of 2009 participants includ-
ing, 616 inmates (total inmates in three main prisons in
the province), 158 injection drug users (those can be
reached) 222 health care workers (based on the population
of health care workers in the province), 49 thalassemic
patients and from other high risk groups as presented in
Table 1. Written informed consent for participation in the
study was obtained from participants, or their parent or
guardian, where participants were children. All sera were
tested for antibodies to hepatitis B core antigen (HBc IgM,
IgG) by enzyme-linked immunosorbent assay (ELISA,
Dialab, Austria). Seropositive specimens were tested for
HBsAg. HBsAg was determined using the Dialab-HBsAg
ELISA Kit (Austria), which utilizes a sandwich immuno-
assay to detect HBsAg. All positive samples were tested
twice for the confirmation of the results. Positive
antibodies to hepatitis B core antigen were considered to
define the presence of HBV infection and chronic infec-
tion was defined when both HBsAg and HBcAb (IgG)
were present.
Collected data were analyzed by SPSS version 17 soft-
ware. The standard chi square test was used to assess
the correlation of demographic and behavioral variables
and HBV infection.
Results
Two thousand and nine high risk people for HBV from
three main townships of Kohgiloyeh & Boyerahmad provi-
dence were included in this study. Among them 802
(39.9%) were from Yasouj, 803 (40%) from Gachsaran and
404 (20.1%) were from Dehdasht. There were 1240 males
(69.1%) and 555 females (30.9%). The mean age of the par-
ticipants was 34.9 years (range, 2 to 82 years). The major-
ity (39.6%) were in the 21–30 year age group.
The overall prevalence of HBV infection in this popula-
tion was 1.2%. Considering the sex of participants, males
were more susceptible to HBV infection. HBV infection
was found to be more prevalent among those who were
working in private sectors (3.8%) in comparison with state
or health care workers. The prevalence of HBV infection
was 3.2% among injection drug users. The highest rate of
infection (4.2%) was seen among immigrant people while
the highest rate of infection among native people was
1.2%. Regarding the place of residence, Yasouj (1.4%) had
the highest rate of infection followed by Gachsaran (1.2%)
and Dehdasht (0.65%). Rate of infection in inmates was
1.2% while none of hemophilia and thalassemia patients
were found to be positive.
Significant associations were identified between HBV in-
fection and sex, history of imprisonment, drug abuse, and
place of residence (p<0.05). No statistically significant as-
sociation was observed between HBV infection and his-
tory of needle stick (in health care workers) (p>0.05).
Regarding the age of participants, 9.5% of subjects were
between 1 to 20 years old, 39.6% between 21 to 30 years,
21.7% between 31 to 40 and the rest were above 40 years
old. Although the highest rate of HBV infection (2.4%)
Table 1 Risk factors associated with HBV infection in high risk groups
Risk factor HBV positive HBV negative Total P value
History of imprisonment 13 (2.1%) 603 616 <0.05
History of using injecting drug 5 (3.16%) 153 158 <0.05
Transfusion 0 (0%) 22 22 >0.05
Needle stick 0 (0%) 222 222 >0.05
Thalassemia 0 (0%) 49 49 >0.05
Hemophilia 0 (0%) 3 3 >0.05
Unprotected sex activities 0 (0%) 16 16 >0.05
Others† 11 (1.19%) 912 923 >0.05
† Tattooing, history of surgery, dental practice, having HBV positive patients in the family.
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was found in participants with less than 20 years old, but
the differences between age and HBV infection was not
significant (p>0.05). The risk factors associated with HBV
infection in high risk groups are presented in Table 1.
Multivariable analysis using logistic regression showed
that history of imprisonment and drug abuse were inde-
pendently associated with HBV infection. Table 2 shows
the details of this correlation.
Discussion
Hepatitis B virus infection is a public health problem and
a major cause of morbidity and mortality particularly in
developing countries [8]. The world can be divided into
three areas where the prevalence of chronic HBV infection
is: high (>8%), intermediate (2-8%), and low (<2%) [8,9].
Most countries in the world are still considered intermedi-
ate to high endemicity for HBV infection [8,9]. In Iran the
prevalence of hepatitis B varies between 1.3 to 6.3% in dif-
ferent areas of the country [10]. Because of lack of infor-
mation about HBV infection in southwest of Iran the
present study was conducted to look at the seroprevalence
of HBV in high risk groups in this area.
A prevalence of 1.2% was found for HBV infection
among the participant in this study. Comparing the find-
ings of this study with other reports from the country,
lower prevalence of HBV can be seen in this area
[10,11]. Findings of this study demonstrated a relatively
low prevalence of HBV in the region. Since the recruited
subjects of this study are the selected high risk groups,
therefore the rate of HBV in whole population of the
district might be different. This low rate of HBV infec-
tion in the province might be connected to HBV vaccin-
ation coverage in this area. National levels of HBV1,
HBV2 and HBV3 vaccination coverage in Iran have been
reported to be 98.9%, 98.8% and 98.4% respectively. Vac-
cination coverage of HBV in Kohgiloyeh and Boyerah-
mad province is up to 99.5% [12].
In a recent study the overall prevalence of HBsAg
positivity among general population in northeast of Iran
was found to be 1.39% which is higher than the rate of
infection in our study [13].
An unexpected observation in this study was that all
positive HBV infections were males. There was no obvi-
ous explanation for the difference in gender, as a risk
factor, for these viral infections. Having no infection in
females might be due to the high risk groups which were
evaluated in this study. Positive cases are all among
those with a history of imprisonment or history of using
injection drugs. More than 95% of these two groups
were males. Furthermore, most of females participants
in this study were either health care workers (with a well
coverage of HBV vaccination), or those with history of
tattooing, history of surgery, etc. and these factors are
not as important as history of imprisonment or history
of using injecting drug. In contrary to our findings, some
studies demonstrated a lower prevalence of HBV infec-
tion in males than females [14].
Intravenous drug users are at higher risk for HBV in-
fection, primarily through high risk sexual activities and
sharing unsterile needles. The prevalence of HBsAg
among male injecting drug users (IDUs) in Tehran, Iran,
was reported to be 5.8% while in Zahedan, Southeast of
Iran, rate of HBV in hospitalized injection drug users
was found to be 19.3% [14]. In another study, the preva-
lence of HBV infection among hospitalized intravenous
drug users in Ahvaz, southwest Iran, was 3.6% [15].
In our study the prevalence of HBV infection among
injection drug users was 3.16% which is slightly lower
than those reported from Tehran or other parts of the
country [14].
Rate of HBV infection in prisoners in our study was
2.1% and a positive correlation was found between being
in prison and seropositivity to HBV. This is again much
lower than the rate of infection in incarcerations in
other parts of the country. A study in south of Iran, in
Bushehr province, reported a rate of 16.7% of HBV in-
fection in prisoners [16].
In our study none of the hemophilic or thalassemic
patients were positive for HBV infection. Repeated blood
transfusions, as in thalessemia cases, are among the highest
risk factors for HBV and HCV infection. In an interesting
study in Bangladesh, the prevalence of transfusion-
mediated viral infections in multi-transfused thalassemics
individuals has been evaluated prior to initiate blood
transfusion and after the subjects have received an average
of 17 blood transfusions over a ten-month study period.
The HBV and HCV markers have been significantly higher
in post-transfused subjects as compared to pre-transfusion
levels (for HBsAg; 19.0 vs. 7.1%) [17]. Correlation between
thalessemia and hemophilia and HBV infection were insig-
nificant in our study and this might be due to the limited
number of cases in our study.
The proper screening of donated blood in blood
banks, regarding HBV infection, and high coverage of
vaccination of people who are afflicted by hemophilia,
thalassemia might be contributed to the low rate of in-
fection in these high risk groups.
Iranian blood transfusion organization (IBTO) is the
only nationally qualified organization in Iran that performs
Table 2 Association between HBs antigen positivity and
high risk behavior in high risk groups in Kohgiloyeh and
Boyerahmad province, southwest of Iran
High risk behavior df Sig. Odd ratio 95.0% C.I. for EXP(B)
Lower Upper
History of drug use 1 .014 4.263 1.273 16.476
History of imprisonment 1 .043 2.170 1.364 8.814
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blood transfusion procedures. This government-based
organization provides its services free of charge. According
to the most recent estimations, there are 23 blood donors
per 1000 population. Only in 2005, the IBTO produced
1,600,000 units of blood for transfusion purposes. Approxi-
mately 96% of blood donations in Iran are collected from
voluntary non-remunerated blood donors and the rest (4%)
is donated as family replacement donation [18]. Khedmat
et al., (2007) reported a rate of 0.487% for HBs antigen in
Iranian blood donors [19].
The finding of this study showed that the people with a
history of vaccination were infected by hepatitis B with a
rate of 0.6% and non-vaccinated people with a rate of 2.3%.
In current study, from all the subjects, 53% had a history of
at least one dose of HBV vaccination. HBV infection was
less prevalent (0.6%) in vaccinated individuals and there
was a significant correlation between increasing number of
vaccine doses and decreasing the rate of HBV infection.
Conclusions
In conclusion, it is essential to assess the magnitude of the
problem of HBV infection in each region of the country.
Findings of the present study provided epidemiological fea-
tures of hepatitis B and its risk factors in Kohgiloyeh and
Boyerahmad province in Southwest of Iran. This informa-
tion may help to restrain the spread of HBV infection in
this and other similar settings in the country. The findings
may also help the health authorities for better implementa-
tion of any prevention and control program.
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